Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardonilizumab + Chemotherapy vs Chemoradiotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
NCT07699185Phase 2Recruiting
- Sponsor
- Tongji Hospital
- Start
- Jan 2024
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 2 trial of cadonilimab in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Tongji Hospital. Started Jan 2024; status: recruiting.
02
Drugs
cadonilimab
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT07699185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07699185.